ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,285, issued on Sept. 23, was assigned to University of Washington (Seattle).
"Micro-dystrophins and related methods of use" was invented by Jeffrey S. Chamberlain (Seattle), Julian Ramos (Seattle) and Stephen D. Hauschka (Seattle).
According to the abstract* released by the U.S. Patent & Trademark Office: "Nucleotide sequences including a micro-dystrophin gene are provided. The micro-dystrophin genes may be operatively linked to a regulatory cassette. Methods of treating a subject having, or at risk of developing, muscular dystrophy, sarcopenia, heart disease, or cachexia are also provided. The methods may include administering a pharmaceutical composition including the micro-dy...